Addition of histone deacetylase inhibitors in combination therapy.
Carraway
Hetty E
HE
Gore
Steven D
SD
D000903:Antibiotics, Antineoplastic / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D015251:Epirubicin / Q000493:pharmacokinetics / Q000627:therapeutic use*; D056572:Histone Deacetylase Inhibitors; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000473:pathology; D059005:Topoisomerase II Inhibitors; D014635:Valproic Acid / Q000493:pharmacokinetics / Q000627:therapeutic use*
D000903:Antibiotics, Antineoplastic; D004791:Enzyme Inhibitors; D056572:Histone Deacetylase Inhibitors; D059005:Topoisomerase II Inhibitors; D015251:Epirubicin; D014635:Valproic Acid